Skip to content Skip to footer

RUSSIA’S SPUTNIK V VACCINE IS 91.6% EFFECTIVE AGAINST SYMPTOMATIC COVID-19, INTERIM TRIAL RESULTS SUGGEST

By Zamira Rahim, CNN Updated 1433 GMT (2233 HKT) February 2, 2021 After criticism last year for an early rollout, Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19 and 100% effective against severe and moderate disease, according to an interim analysis of the vaccine's Phase 3 trial results. The preliminary…

Read more

RUSSIA’S PIONEERING SPUTNIK V COVID-19 VACCINE SENT TO GENEVA FOR APPROVAL FROM WORLD HEALTH ORGANIZATION (WHO)

The creators of Sputnik V, the world's first registered Covid-19 vaccine, have applied for official certification from the World Health Organization (WHO). The groundbreaking Russian vaccine is currently being evaluated in Geneva. Speaking to radio station Echo of Moscow, the WHO's representative in Russia, Melita Vujnovic, explained that…

Read more

The World Health Organization (WHO) is in discussions with the Russian institute that developed the Sputnik V vaccine against COVID-19 over its potential application for emergency use.

In a statement to Reuters, the WHO said: "We look forward to receiving the data for their Sputnik V candidate vaccine. If a product submitted for assessment is found to meet the criteria for listing, WHO will publish the results widely." By granting the vaccine emergency use listing, the WHO…

Read more